CMS Open Payments · Program Year 2024
Fisher & Paykel Healthcare Limited
Fisher & Paykel Healthcare Limited reported $1,131,204.67 across General Payments, Research, and Ownership to 25 physicians and teaching hospitals across 33 transactions.
- $1.1M Above-median payer
- All-tracks total
- 33 Below-median volume
- Transactions
- 25 Below-median reach
- Recipients
- −$98.6K
- General Payments vs PY2023
Fisher & Paykel Healthcare Limited reported $1,131,204.67 across all CMS Open Payments tracks (General + Research + Ownership) to 25 physicians and teaching hospitals in Program Year 2024 - ranking #592 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $81,554.67, averaging $45.2K per recipient.
How Fisher & Paykel Healthcare Limited's $1.1M all-tracks total breaks down
Fisher & Paykel Healthcare Limited's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
26/100
Total payments
F
20/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer fisher-paykel-healthcare-limited Fisher & Paykel Healthcare Limited
$1.1M · #592/1,925 · 0.0% industry · PY2024
- TOT $1.1M
- RANK #592
- SHARE 0.0%
- TXN 33
- RCP 25
- CAT 5
- GEN $81.6K
- ΔGEN −$98.6K
- TOP1 47.8%
- PY 2024
Volume peers
Nearest volume peer: Avanos Medical ($1.1M)
Fisher & Paykel Healthcare Limited sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Fisher & Paykel Healthcare Limited's CMS-reported General Payments decreased by $98.6K (−54.7%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: FISHER & PAYKEL HEALTHCARE LIMITEDPY2023: FISHER & PAYKEL HEALTHCARE LIMITEDPY2024: Fisher & Paykel Healthcare Limited. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $180,146.27
- PY2024
- $81,554.67
What the Data Shows for Fisher & Paykel Healthcare Limited
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Fisher & Paykel Healthcare Limited, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
"Consulting Fee" leads the 5-category general-payment breakdown below at $59.2K (72.6% of General Payments, 8 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
"Consulting Fee" leads Fisher & Paykel Healthcare Limited's 5-category general-payment breakdown at $59.2K, 72.6% of the reported total.
Fisher & Paykel Healthcare Limited reports 5 general-payment categories - the top three are Consulting Fee (72.6%), Travel and Lodging (23.6%), and Honoraria (3.4%). The remaining 2 categories make up 0.4% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Fisher & Paykel Healthcare Limited divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $59.2K | 8 | 72.6% |
| Travel and Lodging | $19.2K | 6 | 23.6% |
| Honoraria | $2.8K | 5 | 3.4% |
| Food and Beverage | $216.21 | 3 | 0.3% |
| Gift | $90.00 | 3 | 0.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $79,739.70 (97.8%) of $81,554.67 in this company's General Payments records across 14 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Fisher & Paykel Healthcare Limited
The five named recipients with the highest reported General Payments from this company
- 1
JOSEPH Ojile
$39,000.00 across 5 reported transactions
- 2
DAVID Rapoport
$38,839.70 across 6 reported transactions
- 3
KEITH Van Dusen
$650.00 across 1 reported transactions
- 4
SHANNON Page
$650.00 across 1 reported transactions
- 5
GEM Ashby
$600.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Fisher & Paykel Healthcare Limited's spend rank (#592 of 1,925, top 31% by spend) and concentration rank (#403 of 1,838, top 22% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- McKesson Drug Company LLC : $30.7K total payments, HHI 4613
- Ellex, Inc : $41.6K total payments, HHI 4605
- Haag-Streit USA, Inc. : $195.6K total payments, HHI 4605
- NeuraSignal Inc. : $8.3K total payments, HHI 4575
- Heru, Inc. : $11.0K total payments, HHI 4571
- Actuated Medical, Inc. : $8.0K total payments, HHI 4564
- Fisher & Paykel Healthcare Limited (this company) : $81.6K total payments, HHI 4558
- Clarius Mobile Health Corp. : $60.4K total payments, HHI 4555
- Cala Health, Inc. : $93.4K total payments, HHI 4549
- Draeger Medical Systems, Inc : $61.0K total payments, HHI 4539
- Konica Minolta Healthcare Americas, Inc : $40.7K total payments, HHI 4538
- HealthTronics Stone Solutions, LLC : $3.2K total payments, HHI 4526
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Fisher & Paykel Healthcare Limited's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Fisher & Paykel Healthcare Limited.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Fisher & Paykel Healthcare Limited.
Showing 6 of 1,924 companies with CMS-reported payment data.
Gynesonics, Inc.
Ossio Ltd
Medartis Inc.
Arrow International, Inc.
Guard Medical SAS
Put this to use
Fisher & Paykel Healthcare Limited ranks #592 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where Fisher & Paykel Healthcare Limited sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Fisher & Paykel Healthcare Limited. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.